Kusajili – Clinical trials directory

Result of your search per sponsor: Min Ja Kim, Professor

Woman and Man Max 99 years
Min Ja Kim, Professor Update Il y a 4 ans

GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock This study is to determine whether the intravenous application of 'Ⅳ-Globulin S inj. (Human Immunoglobulin G)' can reduce mortality in patients with severe sepsis or septic shock.

Country Korea, Republic of
organs None
Specialty None

Closed trial

More information